alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT
      32.1








GVI
      SECURITY SOLUTIONS, INC.


CERTIFICATION
      PURSUANT TO


18
      U.S.C.
      SECTION 1350,


AS
      ADOPTED PURSUANT TO


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002











In
      connection with the Annual Report of GVI Security Solutions, Inc. (the
“Company”) on Form 10-K for the year ending December 31, 2006 as filed with the
      Securities and Exchange Commission on the date hereof (the “Report”), I, Joseph
      Restivo, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
      Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
      of
      2002, that to the best of my knowledge:





(1)
            The
                Report fully complies with the requirements of Section 13(a) or 15(d)
                of
                the Securities Exchange Act of 1934; and





(2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and result of operations of the
                Company.








March
      29,
      2007


/s/
      Joseph Restivo


Joseph
      Restivo


Chief
      Financial Officer
Exhibit 4.39

 

Supplemental Agreement to the Loan Agreement

 

No.

 

This Agreement (the “Agreement”) is entered into and executed by and between the following Parties on August 31, 2012:

 

Party A: Ku6 Media Co., Ltd.

 

Party B:Shanda Games Limited

 

Each of Party A and Party B shall be referred to as the “Party” and collectively, the “Parties”.

 

Whereas

 

1.              Party A and Party B entered into a Loan Agreement dated as of December 27, 2010 (“Original Agreement”), pursuant to which Party B borrowed from Party A US$ 6,600,000 (the “Original Loan”) at the interest rate of 0.6% p.a. ;

 

2.              The maturity date for the Original Loan under the Original Agreement was July 1, 2011, which was extended to August 10, 2012 pursuant to a Renewal Agreement of Loan Contract dated as of April 10, 2012;

 

3.              In May 2012, Party B paid off 50% of the outstanding principle amount of and interest on the Original Loan ;

 

4.              Party B proposes to further extend the maturity date of the remaining balance of the principle amount of the Original Loan (together with all and any accrued but unpaid interest) (the “Loan”) and Party A agrees accordingly.

 

Under the principles of good faith, equality, mutual benefits and common development, through friendly negotiations, the Parties reach the following terms and conditions in respect to the Loan in accordance with Hong Kong law:

 











 

Section 1.  Principle Amount

 

The total principal amount of the Loan is US$3,349,667.10.

 

Section 2.  Maturity Date

 

Party B agrees to pay off the outstanding principle amount of the Loan plus all and any accrued but unpaid interest on the Loan on February 20, 2013.

 

Section 3.  Interests

 

The Loan will hear an interest of 3% per annum and the interest are payable at the maturity date.

 

Section 4.  Other Provisions

 

Except as modified in this Agreement, all other terms and conditions of the Original Loan as specified in the Original Agreement shall remain full force and effect and apply to the Loan under this Agreement.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 











 

The Parties have procured their duly authorized representatives to sign this Agreement on the date first written above:

 

 

	
Party A: Ku6 Media Co., Ltd.
    	
 
    
	
 
    	
 
    
	
Authorized Representative (Signature):
    	
/s/ Yu Shi
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
Party B: Shanda Games Limited
    	
 
    
	
 
    	
 
    
	
Authorized Representative (Signature):
    	
/s/ Xiangdong Zhang
# C_2015338EN.01000101.xml

| 13.10.2015 | EN | Official Journal of the European Union | C 338/1 |
| --- | --- | --- | --- |

13.10.2015

EN

Official Journal of the European Union

C 338/1

---

Non-opposition to a notified concentration

(Case M.7768 — Exor/PartnerRe)

(Text with EEA relevance)

(2015/C 338/01)

On 7 October 2015, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in the English language and will be made public after it is cleared of any business secrets it may contain. It will be available:

1

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32015M7768. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32015M7768. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---
Draft Proposal CB-14 

This concept has been developed by the DOE Building Energy Codes Program (BECP) as a possible code

change proposal to the Commercial provisions of the 2012 International Energy Conservation Code

(IECC).   Interested parties are asked to submit any and all comments on DOE's initial concepts and draft

code change proposals. For instructions on submitting comments, visit:

www.energycodes.gov/development/commercial/codes/iecc/concepts/

Above Grade Wall Provisions (CB-14) 

Objective:  Clarify the provisions in the code related to above‐grade walls.

Suggested Code Change Proposal

Revise Section C402.2.3 as follows:  

C402.2.3 Thermal resistance of above-grade walls. The minimum thermal resistance (R-value) of the 

insulating materials installed in the wall cavity between the framing members, where required, and 

continuously on the walls, where required, shall be as specified in Table C402.2, based on framing type 

and construction materials used in the wall assembly. The R-value of integral insulation installed in 

concrete masonry units (CMU) shall not be used in determining compliance with Table 402.2. 

(Remainder unchanged.)

Reason: The current code indicates that the insulation is to be applied both between framing members

and continuously on the wall.  This is not always the case in some climate zones and is never the case for

mass walls.  Adding the words “where required” allows for cases where either is required or both are

required..

Cost Impact:   There is no cost impact associated with this proposed change.
**Exhibit 24.8**

 

**POWER OF ATTORNEY**

 

KNOW ALL MEN BYTHESE PRESENTS, that the undersigned hereby constitutes and appoints Robert E.Sulentic, Derek R. McClain, Arlin E. Gaffner and J. Christopher Kirk and eachof them, his true and lawful attorneys-in-fact, with full power of substitutionand resubstitution, for him and in his name, place and stead, to sign on hisbehalf, as a director or officer, or both, as the case may be, of Trammell CrowCompany, a Delaware corporation (the “Corporation”), the Corporation’s AnnualReport on Form 10-K for the year ended December 31, 2004, and to sign anyor all amendments to such Form 10-K, and to file the same, with all exhibitsthereto, and other documents in connection therewith, with the Securities andExchange Commission, granting unto said attorneys-in-fact, and each of themwith or without the others, full power and authority to do and perform each andevery act and thing requisite and necessary to be done in and about thepremises, as fully to all intents and purposes as he might or could do inperson, hereby ratifying and confirming all that each of said attorneys-in-factor their substitute or substitutes may lawfully do or cause to be done byvirtue hereof.

 

 
|   | /s/ JEFFREY  M. HELLER |   |
|--------|------------------------|--------|
|   | Jeffrey  M. Heller     |   |

 

----
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Board of Scientific Counselors, National Advisory Neurological Disorders and Stroke.

The meeting will be closed to the public as indicated below in accordance with the provisions set forth in sections 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute of Neurological Disorders and Stroke, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Board of Scientific Counselors, National Institute of Neurological Disorders and Stroke.                    

*Date:*                         May 17-19, 2015.                    

*Time:*                         7:00 p.m. to 10:30 a.m.                    

*Agenda:*                         To review and evaluate personal qualifications and performance, and competence of individual investigators.                    

*Place:*                         Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814.                    

*Contact Person:*                         Alan P. Koretsky, Ph.D., Scientific Director, Division of Intramural Research, National Institute of Neurological Disorders and Stroke, NIH, 35 Convent Drive, Room 6A908, Bethesda, MD 20892, (301) 435-2232,                         *koretskya@ninds.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS).

Dated: March 26, 2015.

Carolyn Baum,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2015-07342 Filed 3-31-15; 8:45 am]

BILLING CODE 4140-01-P
# Historical Data

Use the links below to view the historical data for each survey. Data are in Adobe PDF or Microsoft Excel file format. 

## 2010 Third Quarter Excel [104kb] Second Quarter Excel [107kb] First Quarter Excel [154kb] 

## 2009 Fourth Quarter Excel [114kb] Third Quarter Excel [92kb] Second Quarter Excel [76kb] First Quarter Excel [71kb] 

## 2008 Fourth Quarter Excel [81kb] Third Quarter Excel [76kb] Second Quarter Excel [71kb] First Quarter Excel [67kb] 2006 Annual Report PDF [1.4mb] 2005 Annual Report PDF [1.1mb] 2004 Annual Report PDF [1.1mb] Advance Report for Fourth Quarter 2006 PDF [487kb] Advance Report for Fourth Quarter 2005 PDF [487kb] You are here: Census.gov › Business & Industry › Manufacturing › Survey of Plant Capacity Utilization › Historical Data

Source: U.S. Census Bureau | Survey of Plant Capacity Utilization | (301) 763-4667 | Last Revised: December 16, 2010 

## Quarterly Survey of Plant Capacity Utilization

Annual Survey of Plant Capacity Utilization Manufacturers' Utilization of Plant Capacity 3/14/2011 Survey of Plant Capacity Utilization > H...

census.gov/manufacturing/.../index.html 1/1
EXHIBIT 23.1CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMWe consent to the incorporation by reference in Registration Statement Nos. 333-132152 and333-132800 on Form S-8 of our report dated March 30, 2006 (which report expresses an unqualifiedopinion and includes explanatory paragraphs relating to a change in method of accounting for assetretirement obligations in 2003 and the merger of Mariner Energy, Inc.’s parent company on March 2,2004), relating to the financial statements of Mariner Energy, Inc. appearing in this Annual Reporton Form 10-K of Mariner Energy, Inc. for the year ended December 31, 2005./s/ Deloitte & Touche LLPHouston, Texas
Exhibit 32.1   CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Quarterly Report of IGI Laboratories, Inc. (the Company) on Form 10-Q for the period ending September 30, 2009, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Hemanshu Pandya, President and Chief Executive Officer of the Company, state and certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  Date: November 12, 2009  /s/ Hemanshu PandyaHemanshu Pandya
President and Chief Executive Officer
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 16-7026

UNITED STATES OF AMERICA,

Plaintiff – Appellee,

v.

DERRICK SIMMONS,

Defendant - Appellant.

Appeal from the United States District Court for the District of 

South Carolina, at Spartanburg. Henry M. Herlong, Jr., Senior

District Judge. (7:07-cr-00294-HMH-12; 7:16-cv-02004-HMH)

Submitted: November 22, 2016 Decided: December 2, 2016

Before WYNN, DIAZ, and HARRIS, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Derrick Simmons, Appellant Pro Se. Andrew Burke Moorman, 

William Jacob Watkins, Jr., OFFICE OF THE UNITED STATES 

ATTORNEY, Greenville, South Carolina, for Appellee.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Derrick Simmons seeks to appeal the district court’s order 

denying relief on his 28 U.S.C. § 2255 motion. The order is not 

appealable unless a circuit justice or judge issues a 

certificate of appealability. 28 U.S.C. § 2253(c)(1)(B) (2012). 

A certificate of appealability will not issue absent “a 

substantial showing of the denial of a constitutional right.” 

28 U.S.C. § 2253(c)(2) (2012). When the district court denies 

relief on the merits, a prisoner satisfies this standard by 

demonstrating that reasonable jurists would find that the 

district court’s assessment of the constitutional claims is 

debatable or wrong. Slack v. McDaniel, 529 U.S. 473, 484 

(2000); see Miller-El v. Cockrell, 537 U.S. 322, 336-38 (2003). 

When the district court denies relief on procedural grounds, the 

prisoner must demonstrate both that the dispositive procedural 

ruling is debatable, and that the motion states a debatable 

claim of the denial of a constitutional right. Slack, 529 U.S. 

at 484-85. 

We have independently reviewed the record and conclude that 

Simmons has not made the requisite showing. Accordingly, we 

deny leave to proceed in forma pauperis, deny a certificate of 

appealability and dismiss the appeal. We dispense with oral 

argument because the facts and legal contentions are adequately 
3

presented in the materials before this court and argument would 

not aid the decisional process.

DISMISSED
EXHIBIT 23.1:     Consent of Deloitte & Touche LLP
--------------------------------------------------


INDEPENDENT AUDITORS' CONSENT

We consent to the  incorporation  by reference in  Registration  Statements  No.
333-16115,  No. 333-16117,  No. 333-16121,  No. 333-76631,  and No. 333-93227 of
InteliData  Technologies  Corporation on Form S-8 and in Registration  Statement
No. 333-85313 of InteliData  Technologies  Corporation on Form S-3 of our report
dated March 14, 2001, appearing in this Annual Report on Form 10-K of InteliData
Technologies Corporation for the year ended December 31, 2000.

/s/ DELOITTE & TOUCHE LLP

McLean, Virginia
March 26, 2001
-84 -82 -80 -78 -76 -74

38 40 42



### ★ ▲ ▲ ▲ ▲



### ★ ▲ ▲ ▲ ▲ 500 1000 1500 1000 18 12 06 00 07/17 

### NOAA HYSPLIT MODEL 

## Backward trajectory ending at 2300 UTC 17 Jul 06

EDAS Meteorological DataSource★at 38.92 N 77.01 WMeters AGL
# C_2016027EN.01000101.xml

| 25.1.2016 | EN | Official Journal of the European Union | C 27/1 |
| --- | --- | --- | --- |

25.1.2016

EN

Official Journal of the European Union

C 27/1

---

Last publications of the Court of Justice of the European Union in the Official Journal of the European Union

Official Journal of the European Union

(2016/C 027/01)

Last publication

Last publication

OJ C 16, 18.1.2016

Past publications

Past publications

OJ C 7, 11.1.2016

OJ C 429, 21.12.2015

OJ C 414, 14.12.2015

OJ C 406, 7.12.2015

OJ C 398, 30.11.2015

OJ C 389, 23.11.2015

These texts are available on:

EUR-Lex: http://eur-lex.europa.eu

---
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 2848 Introduced in Senate (IS)]

<DOC>

117th CONGRESS
  1st Session
                                S. 2848

  To exempt individuals with a personal health concern from complying 
    with a Federal COVID-19 vaccine mandate, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           September 23, 2021

    Mr. Lee introduced the following bill; which was read twice and 
  referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL

 
  To exempt individuals with a personal health concern from complying 
    with a Federal COVID-19 vaccine mandate, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Your Health Comes First Act''.

SEC. 2. PERSONAL HEALTH EXEMPTION FROM COVID-19 VACCINE MANDATES.

    (a) In General.--Any COVID-19 vaccine mandate issued by an Act of 
Congress or by an executive agency shall include an exemption for any 
individual who has a concern with such mandate relating to that 
individual's health.
    (b) Definitions.--In this section:
            (1) COVID-19 vaccine mandate.--The term ``COVID-19 vaccine 
        mandate'' means any requirement that an individual receive a 
        COVID-19 vaccine, including any requirement that an employer 
        require an employee or independent contractor to receive such a 
        vaccine.
            (2) Executive agency.--The term ``executive agency'' has 
        the meaning given such term in section 105 of title 5, United 
        States Code.
    (c) Rule of Construction.--Nothing in this section shall be 
construed to allow for or otherwise authorize a COVID-19 vaccine 
mandate issued by an Act of Congress or by an executive agency.
                                 <all>
```
**Exhibit 23.1**

 

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

 

The Board of Directors and Stockholders 

Tumbleweed Communications Corp.: 

 

We consent to the incorporation by reference in the registration statements (Nos. 333-84683, 333-43194, 333-48636, 333-49492, 333-61076, 333-101018,333-103043, 333-106913, 333-114340, and 333-114780) on Form S-8 of Tumbleweed Communications Corp. and subsidiaries of our reports, dated March 15, 2005, relating to the consolidated balance sheets of Tumbleweed Communications Corp. and subsidiariesas of December 31, 2004 and 2003, and the related consolidated statements of operations, stockholders’ equity and comprehensive loss, and cash flows for each of the years in the three-year period ended December 31, 2004, and management’sassessment of the effectiveness of internal control over financial reporting as of December 31, 2004 and the effectiveness of internal control over financial reporting as of December 31, 2004, which reports appears in the December 31, 2004 annualreport on Form 10-K of Tumbleweed Communications Corp. 

 

/s/    KPMG LLP 

 

Mountain View, California 

March 15, 2005
II 

117TH CONGRESS 

1ST SESSION S. 2851 

To require an audit of COVID–19 relief funding. 

IN THE SENATE OF THE UNITED STATES 

SEPTEMBER 23, 2021 

Mr. LEE introduced the following bill; which was read twice and referred to 

the Committee on Homeland Security and Governmental Affairs 

A BILL 

To require an audit of COVID–19 relief funding. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Transparency in 

5 COVID–19 Expenditures Act’’. 

6 SEC. 2. COVID–19 RELIEF FUNDING AUDIT. 

7 (a) IN GENERAL.—The Comptroller General of the 

8 United States shall conduct an audit of the use of all fund9 ing provided by the legislation described in subsection (b) 

10 and submit a report on the findings of such audit to Con11 gress. 


pbinns on DSKJLVW7X2PROD with BILLS
2 

•S 2851 IS

1 (b) LEGISLATION.—The legislation described in this 

2 subsection includes the following: 

3 (1) The Coronavirus Preparedness and Re4 sponse Supplemental Appropriations Act, 2020 

5 (Public Law 116–123). 

6 (2) The Families First Coronavirus Response 

7 Act (Public Law 116–127). 

8 (3) The Coronavirus Aid, Relief, and Economic 

9 Security Act (Public Law 116–136). 

10 (4) The Paycheck Protection Program and 

11 Health Care Enhancement Act (Public Law 116– 

12 139). 

13 (5) Divisions M and N of the Consolidated Ap14 propriations Act, 2021 (Public Law 116–260). 

15 (6) The American Rescue Plan Act of 2021 

16 (Public Law 117–2). 

Æ 


pbinns on DSKJLVW7X2PROD with BILLS